Cite

Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data.

MLA

Goss Sawhney, Tia, et al. “Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data.” Crohn’s & Colitis 360, vol. 5, no. 4, Sept. 2023, p. otad051. EBSCOhost, https://doi.org/10.1093/crocol/otad051.



APA

Goss Sawhney, T., Dobes, A., & O’Charoen, S. (2023). Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data. Crohn’s & Colitis 360, 5(4), otad051. https://doi.org/10.1093/crocol/otad051



Chicago

Goss Sawhney, Tia, Angela Dobes, and Sirimon O’Charoen. 2023. “Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data.” Crohn’s & Colitis 360 5 (4): otad051. doi:10.1093/crocol/otad051.